Over Half of NMN and NR Supplements Fail Label Claims, Testing Reveals
Independent testing exposes widespread quality failures in NAD+ precursor supplements, with actionable guidance on which brands actually deliver.
Summary
A 2026 product review analysis of popular NMN, NR, and NAD+ supplements reveals alarming quality failures across the category. Over half of tested products failed to meet label claims, and in 2021, 64% of top NMN products contained undetectable levels of active ingredient. The review evaluated six leading brands — PartiQlar Pure NMN, Tru Niagen, Omre NMN+Resveratrol, Wonderfeel Youngr, Nutricost NAD+, and Life Extension NAD+ Cell Regenerator — across evidence quality, third-party testing, and price. Key takeaways: NR supplements showed the worst failure rate at 87%, standard NAD+ supplements have poor bioavailability unless liposomal, and consumers should demand Certificates of Analysis before purchasing. Tru Niagen and PartiQlar emerged as top-rated options backed by the strongest evidence and verification standards.
Detailed Summary
NAD+ and its precursors NMN and NR have become among the most popular longevity supplements on the market, driven by compelling preclinical data and a growing body of human trials. But a new product review analysis raises serious concerns about whether consumers are actually getting what they pay for — and whether that matters for health outcomes.
The review compiled third-party testing data, clinical evidence, and expert verdicts for six top-selling NAD+ precursor supplements. The findings are striking: 87% of NR supplements and 55% of NAD+ products reportedly failed to meet label claims in independent testing. A 2021 analysis of NMN products found that 64% had undetectable NMN levels, and 14% contained none at all. This represents a systemic quality control problem in one of the fastest-growing supplement segments.
Among evaluated brands, Tru Niagen (300 mg NR as patented Niagen®) received the strongest overall rating, backed by over 40 clinical studies and NSF-certified third-party testing with publicly available Certificates of Analysis. PartiQlar Pure NMN was rated best-in-class for NMN, offering 500 mg per serving at approximately $1.73, with third-party verification. Budget-oriented standard NAD+ supplements like Nutricost were flagged for poor bioavailability unless formulated as liposomal products.
The review also highlights practical red flags: Amazon-only sellers carry elevated counterfeit risk, and consumers should look for patented ingredient forms (e.g., Niagen® vs. generic NR hydrogen malate) as a proxy for quality assurance.
For clinicians recommending NAD+ precursors, this analysis underscores the importance of directing patients toward brands with verifiable third-party testing. The gap between marketed and actual ingredient content could meaningfully undermine any therapeutic benefit, making sourcing decisions as important as dosing decisions.
Key Findings
- 87% of NR supplements and 55% of NAD+ products failed to meet label claims in independent testing.
- In 2021, 64% of top NMN products had undetectable NMN; 14% contained no active ingredient at all.
- Standard NAD+ supplements have only 10–20% bioavailability unless formulated as liposomal products.
- Tru Niagen (Niagen® NR) leads evidence quality with 40+ clinical studies and public Certificates of Analysis.
- Amazon-only sellers pose elevated counterfeit risk; always verify third-party test results before purchasing.
Methodology
This is a product review analysis, not a primary clinical study. It aggregates third-party testing data, published clinical evidence, and expert verdicts for six commercially available NAD+ precursor supplements. Specific testing methodologies and labs behind cited failure rates are not fully disclosed in the source.
Study Limitations
This summary is based on the abstract and product review content only — the underlying primary testing data and full methodology are not independently verified. The review is published on a commercial supplement review blog (aboutnad.com), which may have affiliate relationships with reviewed brands, introducing potential bias. Specific testing labs and protocols behind quoted failure rates are not cited in a manner that allows independent verification.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: